New Silkroutes Group Ltd
SGX:BMT
Intrinsic Value
New Silkroutes Group Ltd. operates as an investment holding company, which engages in healthcare sector. [ Read More ]
The intrinsic value of one
BMT
stock under the Base Case scenario is
2.13
SGD.
Compared to the current market price of 0.26 SGD,
New Silkroutes Group Ltd
is
Undervalued by 88%.
BMT could be a value trap.A value trap occurs when a stock looks inexpensive based on fundamental analysis but fails to reach its intrinsic valuation over time, often due to underlying issues not reflected in quantitative data.
Scrutinize beyond numbers; assess long-term potential.
New Silkroutes Group Ltd's market capitalization is 15.9m SGD.
BMT stock price is 0.26 SGD.
BMT stock price (0.26 SGD) is 88% less than its Intrinsic Value (2.13 SGD).
BMT.
BMT's Revenue has dropped by 4% over the past 12 months.
BMT has positive Free Cash Flow for the last twelve months.
BMT's ROE (Return on Equity) for the past 12 months is very high and is equal to 26%.
BMT's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from -2% to -20%, and is approaching profitability.
BMT has a very low three-year average ROE (Return on Equity): 2%. The company is not efficient at transforming stockholders' equity into net income.
BMT's ROE (Return on Equity) has significantly increased in the last 3 years from -87% to 26%.
BMT has positive Gross Profit for the last twelve months.
BMT's Revenue has been falling by 17% per year for the last 3 years.
BMT's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -20%.
BMT has negative Operating Income for the last twelve months.
BMT has negative Net Income for the last twelve months.
BMT's long-term liabilties (60m USD) exceed its long-term assets (28m USD).
BMT's short-term liabilties (61m USD) exceed its short-term assets (27m USD).
BMT has positive Net Debt. This means that the company has more debt (38m USD) than cash and short-term investments (3m USD).
BMT has negative three-year average ROIC (Return on Invested Capital): -28%. The company is not efficient at using invested capital to generate operating income.
BMT's D/E (Debt to Equity) is very low and is equal to -1.19.
BMT's Altman Z-Score is very low and is equal to -6.9.
BMT doesn't generate enough operating income (-4m USD) to safely cover interest payments on its debt (404k USD).
Valuation Backtest
New Silkroutes Group Ltd
Run backtest to discover the historical profit from buying and selling
BMT
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
New Silkroutes Group Ltd
Balance Sheet Decomposition
New Silkroutes Group Ltd
| Current Assets | 27.1m |
| Cash & Short-Term Investments | 3.2m |
| Receivables | 3m |
| Other Current Assets | 20.9m |
| Non-Current Assets | 855k |
| PP&E | 538k |
| Intangibles | 238k |
| Other Non-Current Assets | 79k |
| Current Liabilities | 60.7m |
| Accounts Payable | 15.6m |
| Short-Term Debt | 37.2m |
| Other Current Liabilities | 7.8m |
| Non-Current Liabilities | -656k |
| Long-Term Debt | 802k |
| Other Non-Current Liabilities | -1.5m |
Earnings Waterfall
New Silkroutes Group Ltd
|
Revenue
|
28.1m
USD
|
|
Cost of Revenue
|
-16m
USD
|
|
Gross Profit
|
12.1m
USD
|
|
Operating Expenses
|
-16.2m
USD
|
|
Operating Income
|
-4.1m
USD
|
|
Other Expenses
|
-3.9m
USD
|
|
Net Income
|
-8m
USD
|
Free Cash Flow Analysis
New Silkroutes Group Ltd
What is Free Cash Flow?
BMT Profitability Score
Profitability Due Diligence
New Silkroutes Group Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
Score
New Silkroutes Group Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
BMT Solvency Score
Solvency Due Diligence
New Silkroutes Group Ltd's solvency score is 21/100. The higher the solvency score, the more solvent the company is.
Score
New Silkroutes Group Ltd's solvency score is 21/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BMT Price Targets Summary
New Silkroutes Group Ltd
Shareholder Return
BMT Price
New Silkroutes Group Ltd
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -25% |
| Market Capitalization | 15.9m SGD |
| Shares Outstanding | 61 115 384 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
New Silkroutes Group Ltd
Country
Industry
Market Cap
Dividend Yield
Description
New Silkroutes Group Ltd. operates as an investment holding company, which engages in healthcare sector. The firm operates in the healthcare sector. The Company’s healthcare division focused on the provision of healthcare and related services, and operates through its subsidiary, Healthsciences International Pte. Ltd. (HSI). HSI owns and operates primary care medical and dental clinics in Singapore. The firm has also extended its healthcare portfolio into healthcare-related supplies through its subsidiary, Shanghai Fengwei Garment Accessory Co., Ltd (Shanghai Fengwei) in China. Shanghai Fengwei produces the non-woven material, which is used to manufacture disposable medical consumables, such as hospital gowns and linen, personal protective equipment and masks. The company owns approximately 16 clinics comprising one dental specialist clinic, eight dental clinics, five family medicine clinics, one aesthetic clinic and one traditional Chinese medicine (TCM) clinic, as well as one dental supplies company.
Contact
IPO
Employees
Officers
The intrinsic value of one
BMT
stock under the Base Case scenario is
2.13
SGD.
Compared to the current market price of 0.26 SGD,
New Silkroutes Group Ltd
is
Undervalued by 88%.
You don't have any saved screeners yet
